MGG staining is an essential cytological method for identifying and analyzing circulating tumor cells (CTCs) in the blood. Thanks to its excellent nuclear and cytoplasmic contrast, it highlights the distinctive morphological features of CTCs, providing valuable information for oncology research.
Prostate cancer cell line LNCaP
ScreenCell® technology enables not only MGG staining, but also H&E and RAL555 staining, offering great flexibility to meet the diverse requirements of clinical applications and research projects.
MGG staining is fully compatible with ScreenCell® technology, thanks to kits designed for this analysis. Quick to implement, it preserves the morphology of circulating tumor cells (CTCs) faithfully.
Blood sample
< 4 hours
Cells fixed and analyzed on the isolation support
Cytological
staining
Immunofluorescence
Immunocytochemistry
Fluorescence in situ hybridization
Blood sample
< 3 days
Cytological
staining
Immunofluorescence
Immunocytochemistry
Fluorescence in situ hybridization
Blood sample
< 3 days
ou
Cells fixed detached
from the isolation support for analysis in suspension or on slide
Cytological
staining
Immunofluorescence
Immunocytochemistry
Fluorescence in situ hybridization
Blood sample
< 4 hours
ou
Cells fixed detached
from the isolation support for analysis in suspension or on slide
Cytological
staining
Immunofluorescence
Immunocytochemistry
Fluorescence in situ hybridization
Blood sample
< 4 hours
Living cells detached
from the isolation support for suspension analysis
Cytological
staining
Immunofluorescence
Immunocytochemistry
Fluorescence in situ hybridization
Blood sample < 3 days
or
Fixed cells detached
from the isolation support for analysis in suspension or on slide
Blood sample < 4 hours
or
Fixed cells detached
from the isolation support for analysis in suspension or on slide
Blood sample < 4 hours
Living cells detached
from the isolation support for suspension analysis
No. Thanks to our technology, the membranes of CTCs remain intact, and the internal structures are clearly visible, allowing for detailed analysis without significant artifacts.
Are you interested in establishing a fundamental or clinical research project focused on circulating tumor cells (CTCs) or liquid biopsy ?
Share your project details with us, and we will be delighted to assist you in bringing it to fruition.
